Literature DB >> 220537

Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade.

J A Lopez-Ovejero, S D Saal, W A D'Angelo, J S Cheigh, K H Stenzel, J H Laragh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 220537     DOI： 10.1056/NEJM197906213002505

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

Review 1.  Combination therapies for systemic sclerosis.

Authors:  C P Denton; C M Black
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

3.  Successful treatment of scleroderma renal crisis with enalapril.

Authors:  S R Milsom; M G Nicholls
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

4.  Letter from Chicago: Temples, tubes, and plastic bags.

Authors:  G Dunea
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

Review 5.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 6.  Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Authors:  Masutaka Furue; Chikage Mitoma; Hiroki Mitoma; Gaku Tsuji; Takahito Chiba; Takeshi Nakahara; Hiroshi Uchi; Takafumi Kadono
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

7.  Inhibitors of angiotensin I converting enzyme for treating hypertension.

Authors: 
Journal:  Br Med J       Date:  1980-09-06

8.  Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.

Authors:  B Waeber; M D Schaller; J P Wauters; H R Brunner
Journal:  Klin Wochenschr       Date:  1984-08-01

Review 9.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

10.  A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).

Authors:  J F Fries; C Wasner; J Brown; P Feigenbaum
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.